Treatment-Emergent Adverse Effects of Psychotropic Medication (R01)

The summary for the Treatment-Emergent Adverse Effects of Psychotropic Medication (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Treatment-Emergent Adverse Effects of Psychotropic Medication (R01): -Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Mental Health (NIMH), National Institutes of Health (NIH), invites investigator-initiated research grant applications for studies examining the adverse effects of psychopharmacological medications across the lifespan (including pediatric, adult and geriatric populations). Applications responsive to this FOA should focus on clinical models of the pathophysiology of psychotropic medication adverse effects; genomic, proteonomic or clinical-epidemiological approaches to the identification of high risk populations; the creation of theory-based psychosocial treatments to modify behavioral risk factors for adverse effects such as weight gain; and the development and testing of novel pharmacological approaches to the prevention or mitigation of treatment-emergent side effects. -Mechanism of Support. This FOA will use the NIH Research Project Grant (R01) award mechanism. Applications of identical scientific scope are solicited also under the NIH Small Research Grant (R03), the NIH Exploratory/Developmental Research Grant (R21), and the NIMH Clinical Exploratory/Developmental Research Grant (R34) award mechanisms, responding to FOAs PA-06-180, PA-06-181, and PA-06-248, respectively. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.